536994-10-2Relevant academic research and scientific papers
Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes
-
Paragraph 0325, (2016/06/28)
Disclosed are inhibitors of post-proline cleavage enzymes, such as inhibitors of dipeptidyl peptidase IV, as well as pharmaceutical compositions thereof, and methods for using such inhibitors. In particular, the inhibitors are improved over those in the p
Methods for treating autoimmune disorders, and reagents related thereto
-
Page/Page column 24-25, (2010/02/11)
The invention generally relates to improved methods for treatment or prophylaxis in animal subjects (including humans) of autoimmune disorders including Type I diabetes, septic shock, multiple sclerosis, inflammatory bowel disease (IBD) and Crohn's disease.
